According to Context Therapeutics's latest financial reports the company has a price-to-book ratio of 11.4.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.52 | 407.69% |
2022-12-31 | 0.2994 | -50.45% |
2021-12-31 | 0.6042 | |
2020-12-31 | N/A |